| European Case Law Identifier: | ECLI:EP:BA:2003:T001201.20031202 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 02 December 2003 | ||||||||
| Case number: | T 0012/01 | ||||||||
| Application number: | 90907718.2 | ||||||||
| IPC class: | C12N 15/12 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Human Lactoferrin cDNA Sequence | ||||||||
| Applicant name: | BAYLOR COLLEGE OF MEDICINE | ||||||||
| Opponent name: | Pharming Group NV | ||||||||
| Board: | 3.3.08 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Main request: added matter (no) Sufficiency of disclosure (yes) Entitlement to priority date (yes) Novelty (yes) Inventive step (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t010012eu1.html
Date retrieved: 17 May 2021